Skip to content
Life Sciences Series B Founded 2015

Armonica Technologies

Developer of long-read DNA sequencing technology for precision medicine. The technology used is a nanopore-based sequencing technique for enabling the detection of genome variations. It enables clinicians to provide precision medicine. The company was founded in 2015 and headquartered in Albuquerque, United States. It has raised $7.7M in series b funding, with backing from NHGRI, BFA, Cottonwood Technology Fund,…

📍 Albuquerque, United States · Genomics,

Funding snapshot

Last roundSeries B
Amount$4M
Date10 November 2025
Total raised$8M
Team size5

About

Developer of long-read DNA sequencing technology for precision medicine. The technology used is a nanopore-based sequencing technique for enabling the detection of genome variations. It enables clinicians to provide precision medicine. The company was founded in 2015 and headquartered in Albuquerque, United States. It has raised $7.7M in series b funding, with backing from NHGRI, BFA, Cottonwood Technology Fund, Tramway Venture Partners, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Clinical Genomics space. Within the Life Sciences - Genomics and Life Sciences - Clinical Genomics landscape, the company aims to address evolving market needs through its specialized approach.

Business model

Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Precision Medicine

Institutional investors

NHGRI BFA Cottonwood Technology Fund Tramway Venture Partners Sun Mountain Capital Hamamatsu Photonics HHS NM Vintage Fund

Latest coverage

No articles yet.

Raising like Armonica Technologies?

Analyze your pitch deck before your next raise.

Analyze My Deck →